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Abstract
The ability to control the morphologies of biomolecular aggregates is a central objective in the study of self-assembly pro-
cesses. The development of predictive models offers the surest route for gaining such control. Under the right conditions,
proteins will self-assemble into fibres which may re-arrange themselves even further to form diverse structures, including
the formation of closed loops. In this study chicken egg white ovalbumin is used as a model for the study of fibril loops.
By monitoring the kinetics of self assembly we demonstrate that loop formation is a consequence of end-to-end association
between protein fibrils. A model of fibril formation kinetics including end-joining is developed and solved, showing that end-
joining has a distinct effect on the growth of fibrillar mass density (which can be measured experimentally) establishing a
link between self-assembly kinetics and the underlying growth mechanism. These results will enable experimentalists to infer
fibrillar morphologies from an appropriate analysis of self-assembly kinetic data.
Submitted on October 3, 2014
*Correspondence: [CE MacPhee, SUPA, School of Physics and Astronomy, University of Edinburgh, Mayfield Road,
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INTRODUCTION
The self-assembly of polypeptides into fibrillar aggregates is relevant into areas as diverse as disease pathology (1) and the
synthesis of bio-compatible nanomaterials (2, 3). The formation of “amyloid-like” fibrils, which are rich in β-sheet structure
has been the focus of much research due to the universal nature of the self-assembly process: most if not all proteins can form
amyloid-like fibrils under appropriate (not necessarily physiological) environmental conditions (4). The kinetics of amyloid
fibril formation can be tracked using β sheet-binding dyes such as Congo red or Thioflavin T (Th T) or monitoring turbidity,
while the morphology of the resulting fibrils can be assessed using electron microscopy. However these are usually measured
in separate studies - few attempts have been made to link self-assembly kinetics to fibril morphology. Establishing such a link
would be an important step forward in understanding, predicting and controlling protein aggregation processes.
The kinetics of amyloid-like fibril formation, as measured using spectroscopic assays such as the thioflavin T fluorescence
assay (5–7), are typically characterised by growth curves of a sigmoidal or sigmoidal-like form, in which a quiescent lag
phase - often lasting hours or even days - is followed by rapid growth, culminating in a plateau when monomeric protein is
exhausted or the system reaches equilibrium. The lag phase can be abolished by adding preformed fibril “seeds”, suggesting
that a nucleation process plays a key role. Indeed, theoretical models that include nucleation, growth by monomer addition
at fibril ends and autocatalysis via fibril fragmentation can successfully reproduce these sigmoid-like growth curves (8–10).
Here the role of fibril fragmentation is to form new growth-competent fibril “ends” which accelerate the depletion of monomer
during the growth phase, leading to the characteristic sigmoidal form for the fibril growth curve. These models also predict
characteristic scaling laws for the lag time and maximal growth rate as functions of the protein concentration. An alternative
protein aggregation process may exhibit rapid fibril growth from the very onset with an absence of lag phase - examples of
this phenomenon are cited below.
© 2013 The Authors
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Amyloid fibrils have been observed to form in a wide variety of morphologies, including long rigid fibrils, short rod-like
forms, wide tapes and flexible worm-like chains which are characterised by a shorter persistence length (1, 11). Fibril poly-
morphism may become manifest when the self-assembly takes place under different conditions, as seen for β2-microglobulin
(12), or, alternatively, two forms may arise simultaneously, as observed for amyloid β (13, 14). Intriguingly, a number of
systems that form fibres with worm-like chains have also been observed to form ring or loop structures (e.g. apolipoprotein
C-II (16), α-synuclein (18), the crystallins (19, 20), human serum albumin (21), β-lactoglobulin (22) and αS2-casein (23). The
simplest hypothesis for the formation of loops by protein fibrils is joining of their two ends (24). This hypothesis implies a
link to fibril growth kinetics, since end-joining decreases the number of fibril ends available for growth by monomer addition.
In this study we show that such a link between end-joining and self-assembly kinetics indeed exists, using the 44.5kDa glyco-
protein OVA, the main protein component of avian egg white, as a model system. Due to its abundance, OVA is a convenient
model system for the study of fibril formation. Under acidic or near-neutral conditions (pH ≤ 7) and elevated temperatures,
OVA forms fibrils that display amyloid-like behaviour in that they bind the dyes ThT and Congo Red (25–29) (SI Figures
S1 and S2; Figure 3). The formation of amyloid-like fibrils is more pronounced when the reaction takes place in a reducing
environment (30). Published images of OVA fibres indicate flexible morphologies (28), however under reducing conditions
more rigid fibres have also been observed (30). We investigate in detail the self-assembly kinetics of OVA fibrils, under con-
ditions where flexible fibrils, with some closed loops, are formed. We develop a theoretical model which includes both fibril
fragmentation and the joining of fibril ends. By fitting our model to our experimental data, we show that both fragmentation
and end-joining play important roles in the self-assembly kinetics.
MATERIALS AND METHODS
Preparation of Ovalbumin fibrils
Ovalbumin (isolated from chicken egg white) used in this study was purchased from Sigma (Grade 5; A5503). In order to
produce reduced OVA samples, the lyophilised protein powder was dissolved in aqueous 10mM ammonium acetate 10 mM
dithiothreitol buffer (pH 6.8), achieving the desired protein concentrations (ranging between 0.1 and 12.8 mg/ml). Subse-
quently, the sample, distributed in 1.2 mL aliquots in Eppendorf tubes secured with parafilm, was incubated on a benchtop
block heater at 37◦C for 2 hours. Reduced protein aliquots were mixed, cooled on ice and filtered with a 200 µm cutoff filter.
Fibrils were produced by incubating the samples at 60◦C. Incubation typically occurred in 96-well plates in the plate reader
or on the block heater (in the latter case Eppendorf tubes were secured with parafilm).
Thioflavin T fluorescence kinetics at 60◦C
Fibril formation kinetics were followed by means of the Th T fluorescence assay. Th T was added to reduced protein samples
to a concentration of 55 µM. 100 µL aliquots were added in 96-well plates. Corning Non-Binding surface plates (coated with
a PEG-like polymer) and Nunc-Immuno StarWell Modules (PolySorp surface; polystyrene coating), the latter sealed with
polyethylene caps, were used for these experiments. Both plate types were sealed additionally with a transparent adhesive
plate sealer (Greiner) and secured further with parafilm in order to minimise solvent evaporation. Typically 60 out of a total
of 96 wells contained the protein solution with the remaining 36 being used for blanks. The kinetics were measured using
a BioTek Synergy 2 plate reader. The microplate was kept at a temperature of 60◦C for plate-reader measurements. Th T
fluorescence readings (λexc = 440 nm, λem = 485 nm) were collected every 8 minutes, with a 18Hz shaking frequency
(”medium” setting). Th T binding kinetics were probed for 3-5 days.
Temperature-dependence of Th T binding kinetics
The kinetics of Th T binding were measured on quiescent samples on a Varian Cary Eclipse fluorimeter, fitted with a Peltier
device. 3.0 mL of 6.0 mg/mL reduced protein solution (prepared as described above) was added to 10mm-path quartz cuvettes
(Starna Scientific). The kinetics were monitored for 24 hours, collecting a reading every 10 minutes. OVA Th T binding kinet-
ics were measured at 50, 55, 60, 65, 70 and 80◦C in this fashion. These experiments were repeated in triplicate, with buffer
blanks being measured in duplicate.
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Transmission Electron Microscopy
For TEM, 2.0 µL reduced OVA fibril suspension were deposited on formvar/carbon coated TEM grids (TAAB). The sample
was allowed to equilibrate for 5 minutes after which the excess was removed with a filter paper wedge and washed with 20
µL of distilled H2O, which was then immediately removed. The samples were stained with 1% w/v uranyl acetate. Staining
time ranged between 30 and 45 s. Excess stain was removed and the grids were allowed to dry for at least 20 minutes prior to
analysis.
TEM images were collected on a Phillips CM 120 Biotwin transmission electron microscope and captured by a Gatan
Orius 1000 CCD camera controlled using DigitalMicrograph™ (Gatan, Inc., USA) imaging software. Image analysis was
carried out using the ImageJ program.
Protein Quantitation
Whenever necessary, protein concentrations were determined using the Bradford assay. 10 µL of standard protein solution
or fibril sample (appropriately diluted - 1,2,5 or 10× - in 10 mM NH4CH3COO 10 mM DTT buffer) were dissolved in 200
µL of Bradford reagent. The absorbance was recorded at 450 nm and 595 nm and the ratio of the two readings were used to
construct the standard curve and to determine the concentrations. OVA was used as the protein standard, allowing accurate
concentration determination.
Model for fibril formation by linear growth, end-joining and fragmentation
Our kinetic and morphological observations, presented in Results and Discussion, suggest that OVA fibril formation involves
seeded linear fibril growth, combined with a secondary process, such as end-to-end joining, that can produce loops. Indeed,
a kinetic model that includes seeded linear growth and end-joining (which can be solved analytically; see SI) does predict
rapid fibril growth followed by saturation, similar to what we see in our experiments. However, this model does not reproduce
the second, slower growth regime (Fig. S6); we find a good fit to the experimental data if we also include in the model fibril
fragmentation - i.e., the generation of new fibril ends by breakage of growing fibrils (see Figure 5). This suggests that fragmen-
tation is a significant factor in the self-assembly of OVA, even though its growth kinetics display none of the characteristics
typically associated with fragmentation-based models.
A model for the self-assembly of fibrils which incorporates end-joining and loop formation can be summarised using the
following reaction set, schematically presented in figure 1:
Fi +m
k+−−→ Fi+1 [1]
Fi
kf−⇀↽−
kj
Fi−j + Fj , i, j ≥ nc [2]
F loopi
kf−⇀↽−
kl
Fi [3]
Here, Fi is a single fibril of length i, m is a single monomer, nc is the number of monomers in the smallest stable fibril (fibrils
shorter than nc are assumed to dissolve into monomers) and F
loop
i is a loop of size i. The total monomer concentration is
denoted with m(t). The first reaction describes the elongation of a fibril by addition of a monomer to either of its ends, with
rate constant k+. The second reaction describes the breakage of a fibril of length i at any point between two of its monomers
with rate constant kf ; the opposite process of joining two fibril ends has rate constant kj . The third reaction describes the
breakage of a loop of length i in a similar way to that of a single fibril (N.B. a loop contains one more breakable bond than a
fibril of the same length) with the same rate constant kf ; similarly, in the opposite process a loop is formed with rate constant
kl; this rate is given by kj/V multiplied by the probability Ploop of two ends of a worm-like chain meeting together (16).
The rate equations for the mass density M(t) and the number density N(t) of fibrils may be written as:
dM
dt
= 2k+(mtot −M)N − kfnc(nc − 1)N, M(0) =M0 [4]
dN
dt
= kf [M − (2nc − 1)N ]− kjN2, N(0) = N0, [5]
where mtot represents the total density of protein monomers; N0 and M0 are the initial (“seed”) fibril number density and
fibril mass concentration respectively. Equations ([4])-(5) were derived from the master equation for the number density of
fibrils of sizes i ≥ nc (see Supplemental Material).
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Figure 1: Schematic representation of processes described by the model of reactions (1)-(3), which are also thought to take
place during OVA self-assembly. The process giving rise to the initial seed population is not defined explicitly and instead is
modelled by the presence of a seed population that forms rapidly at early times.
Solving for the steady state of the set of equations (4)-(5) provides an expression for the fibril mass concentration M∗ and
number density N∗, in the long-time limit:
M∗ = mtot − kfnc(nc − 1)
2k+
[6]
N∗ =
√
k2f (2nc − 1)2 + 4kjkfM∗ − kf (2nc − 1)
2kj
. [7]
The dynamical trajectories leading to the state (M∗, N∗) provide predictions for the self-assembly kinetics. These trajecto-
ries can be obtained analytically in an approximate form (assuming small kf and sufficiently large N0), or using numerical
simulations, both of which are described in the following sections.
Analytical solution for the self-assembly kinetics of a model including monomer addition, fragmentation and end-joining
An approximate solution for the set of equations (4) and (5) can be obtained in closed form using the following method, for
the choice of parameters for which m(t) does not develop a sigmoidal shape; a closed form solution for the case where m(t)
develops a sigmoidal shape has been obtained very recently in (17).
First, it is useful to define m =M/M∗ and n = N/N∗, so that the equation is now expressed in terms of the dimension-
less ratio of fibril mass and number density relative to their steady state value. After rescaling the time variable τ = 2k+N∗t,
and assuming kf  k+mtot and kf  kjmtot, the system (4)-(5) can be written as
dm
dτ
= (1−m)n, m(0) =M0/M∗ = m0 [8]
dn
dτ
= −rn2 + rm, n(0) = N0/N∗ = n0, [9]
where r ≡ kj/(2k+) is the ratio of the end-joining to the elongation rate constants. Equation (8) can be integrated yielding
an expression for m(τ) given an expression for n(τ)
m(τ) = 1− (1−m0)e−
∫ τ
0
dτ ′n(τ ′). [10]
At late times n ≈ 1 yielding
m(τ |n→ 1) = 1− (1−m0)e−τ . [11]
Biophysical Journal 00(00) 1–14
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m(τ |n → 1) is a monotonically increasing, concave function and thus may serve as a good approximation to m(τ) at early
times provided m(τ) does not develop a sigmoidal shape. Using this expression as an approximation for m(τ) at early times,
we obtain the following non-linear 1st order ODE for n(τ):
dn
dτ
= −rn2 + r − r(1−m0)e−τ , n(0) = n0. [12]
This equation can be solved (see SI for details):
n(τ) =
u
4r
c[J2r+1(u)− J2r−1(u)] + Y2r+1(u)− Y2r−1(u)
cJ2r(u) + Y2r(u)
, [13]
u = 2r
√
1−m0e−τ/2 [14]
c =
Y2r−1(2r
√
1−m0)− Y2r+1(2r
√
1−m0) + 2n0√1−m0Y2r(2r
√
1−m0)
J2r−1(2r
√
1−m0)− J2r+1(2r
√
1−m0) + 2n0√1−m0 J2r(2r
√
1−m0)
, [15]
Jα(x) and Yα(x) being Bessel functions of the first and second kind respectively. Expression (13) can be integrated and
combined with (10) to obtain the following approximation for m(τ):
m(τ) = 1− (1−m0)
(
cJ2r(2r
√
1−m0) + Y2r(2r
√
1−m0)
cJ2r(2r
√
1−m0e−τ/2) + Y2r(2r
√
1−m0e−τ/2)
)1/r
, [16]
where the constant c is as defined in (15). Plots of the approximate solution given by (13) and (16) are shown in Figure S5
along with curves generated numerically; clearly the agreement between them is excellent.
An expression relating m and n may also be derived from (8)-(9):
n
dn
dm
= − r
1−mn
2 +
rm
1−m. [17]
This is solvable for any n0, r and m:
n(m) =

[(
n20 − 2rm0−12r−1
)(
1−m
1−m0
)2r
+ 2rm−12r−1
]1/2
, r 6= 1/2,[(
n20 − 1
)
1−m
1−m0 + (1−m)ln 1−m1−m0 + 1
]1/2
, r = 1/2.
[18]
This is an exact implicit solution that relates the fibril number and fibril mass densities.
Simulation of the self-assembly process including end-joining
Kinetic (stochastic) Monte Carlo simulations were performed by implementing Gillespie algorithm using Fortran 95 and then
by averaging over 150 replicate simulations for each set of conditions. The number of loops and fibrils were tracked for each
of length, along with the total monomer populationm(t). Length distributions were obtained at points in the simulation where
the total fibril mass had reached a specific threshold (i.e. instead of at particular points in time).
RESULTS AND DISCUSSION
Heat treatment of reduced OVA produces fibrillar aggregates and closed loops with amyloid-like Congo Red and Thioflavin
T binding properties
Incubation of reduced (10 mM DTT) OVA for several hours at 60◦C at near-neutral pH (10 mM ammonium acetate, pH 6.8)
produced species which bound Congo red (see SI figure S1) and Th T. Examination of the heated OVA samples by TEM
revealed the presence of fibrillar aggregates (Figure 2 A-C). The fibrils formed by reduced OVA under these conditions are
flexible with a persistence length of approximately 26 nm (see Fig. S2 in the supplemental material). The fibrils often appeared
to be entangled, particularly at higher protein concentrations, a feature that prevents an accurate determination of their length
distribution. Interestingly, our TEM images often reveal the formation of loops, in which the two ends of a single fibril appear
to be annealed. Loops were observed in TEM images of heat-treated samples at both low (0.4 mg/ml) and high (6.4 and 12.8
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mg/ml) initial concentration of protein (Fig. 2 A-D). The presence of loops in the samples provides clear evidence that fibrils
of length greater than the persistence length can join end-to-end. Analysis of images from samples in which loop formation
was abundant (80◦C, 6.4 mg/ml) showed that the length distribution of fibrils in loops is centred at 120 nm, but skewed
towards longer loops (loops as large as 360 nm in circumference could be seen; see histogram in Fig. 2 E). No loops were
seen with circumference smaller than twice the persistence length, the smallest measured loop having a length of 74 nm.
Figure 2: TEM images of fibrils formed by OVA along with branching angle and fibril diameter distributions. A) Entangled
and branched fibrils formed by 0.4 mg/ml OVA heated at 60◦C. Inset shows an example of a branched fibril. B) Entangled and
branched fibrils formed by 12.8 mg/ml OVA heated at 60◦C. C) Loops formed by 0.4 mg/ml OVA fibrils at 60◦C. D) Loops
formed by 6.4 mg/ml OVA fibrils at 80◦C. E) Experimental length distributions of OVA (6.4 mg/ml, incubated at 80◦C) loops.
The kinetics of OVA self-assembly
The self-assembly kinetics of reduced OVA differs strongly from the standard sigmoidal behaviour, and can be divided into
three regimes (Figure 3 A). In our experiments, fibril mass, as measured by the ThT fluorescence, increases sharply from the
start of the experiment, with no apparent lag phase (although at very early times, our measurements are obscured by a transient
behaviour that we attribute to temperature fluctuations). This initial growth phase is followed by a second growth regime,
where the ThT fluorescence continues to increase but considerably more slowly, following which, the ThT fluorescence
reaches a plateau.
The absence of a lag phase suggests that fibril formation in our experiments does not proceed via a classic homogeneous
nucleation and growth mechanism by monomer addition. This interpretation is supported further by measurements of the
relationship between protein concentration and the initial growth rate (Figure 3 B). For a mechanism involving homogeneous
nucleation and growth, one would expect that the initial aggregation rate, in the absence of seeds, to be equal to the initial
nucleation rate, which can be assumed to scale as [protein concentration]nc (for rate-limited reactions), nc ≥ 2 being the size
of the nucleus. However, as shown in Figure 3 B, in our experiments the initial aggregation rate scales linearly with protein
concentration, suggesting that a process other than homogeneous nucleation must give rise to the initial population of growth-
competent species. We also noticed that the initial aggregation rate was influenced by the material of the vessel in which our
experiments were performed, with aggregation in microplates coated with a PEG-like polymer occurring substantially faster
than in uncoated plates (see SI for details). The initial aggregation rate also depends on the volume of the sample, with sam-
ples with a smaller surface area to volume ratio exhibiting less growth (see Figure S3 D-E). These findings suggest that fibril
growth is seeded at the walls of the sample container. For seeded growth, the initial growth rate is controlled by the initial
monomer addition rate, which scales linearly with number of seeds and protein concentration. If the surface is saturated with
fibril seeds, then the number of seeds is independent of protein concentration, which would give rise to the observed linear
scaling of the initial rate with protein concentration.
Biophysical Journal 00(00) 1–14
A kinetic study of ovalbumin fibril formation 7
0 1 x 1 0 5 2 x 1 0 5 3 x 1 0 5
0
2 0 0 0
4 0 0 0
6 0 0 0
8 0 0 0
0 . 0 1 0 . 1 1 1 0 1 0 0
1 E - 4
1 E - 3
0 . 0 1
0 . 1
1
 
Flu
o. I
nte
nsit
y (A
.U.)
t i m e  ( s )
A
 
Initi
al R
ate
 (A.
U. s
-1 )
c o n c e n t r a t i o n  ( m g  m l - 1 )
B
0 2 4 6 8 1 0 1 2 1 40 . 0
0 . 5
1 . 0
1 . 5
2 . 0
2 . 5
3 . 0
0 2 4 6 8 1 0 1 2 1 4
1 . 0 x 1 0 - 5
1 . 2 x 1 0 - 5
1 . 4 x 1 0 - 5
1 . 6 x 1 0 - 5
1 . 8 x 1 0 - 5
2 . 0 x 1 0 - 5
2 . 2 x 1 0 - 5
0 2 4 6 8 1 0 1 2 1 40 . 0
0 . 2
0 . 4
0 . 6
0 . 8
1 . 0
 
 
k j/2
k +
c o n c e n t r a t i o n  ( m g  m l - 1 )
C
 
 
2N*
k + (
s-1 )
c o n c e n t r a t i o n  ( m g  m l - 1 )
D
 
 
N 0/N
*
c o n c e n t r a t i o n  ( m g  m l - 1 )
E
Figure 3: OVA self-assembly kinetics monitored by thioflavin T binding. A) Kinetic traces of ThT binding by OVA between
0.4-12.8 mg/ml. Symbols represent the experimental data; fitted curves according to equation (16) are shown as red solid
lines. B) log-log plot of the initial growth rate vs. concentration (red line represents a linear scaling relation). C) Concentra-
tion dependence of the ratio of end-joining and growth rate constants. Interestingly, this factor decreases with concentration,
possibly reflecting the lower diffusivity of the initial seed population in concentrated mixtures (which may arise since the
effect of fibril length on growth is not taken into account by the model). D) Concentration dependence of the time-scaling
factor 2k+N∗. While this factor increases with concentration, the observed dependence is much weaker than the one pre-
dicted from the theory (Eq. 7). E) Concentration dependence of the ratio N0/N∗. Since N∗ is only weakly dependent on
concentration, a constant ratio of N0/N∗ ≈ 0.5 predicts that N0 is concentration independent, a necessary condition for the
model to be consistent with the linear concentration scaling of the initial rate (B).
Theoretical analysis of the model for fibril formation by linear growth, end-joining and fragmentation
Results for the theoretical trajectories of the model described by equations (8)-(9) reveal qualitatively different types of
dynamical behaviour, depending on the parameters - in particular on the initial concentration of seed fibrils N0 (see the phase
diagram shown in Figure 3 A).
For small seed densityN0  N∗ (i.e. if the initial concentration of seeds is much smaller than the long-time fibril density),
the model predicts sigmoidal kinetics for the fibril mass M . In this case, the only apparent effect of end-joining is to smooth
out the transition between the rapid growth phase and the plateau (Figure 4 B and C, n0 = 0.001). By taking the kinetics
of the fibril number density N(t) into account, we may distinguish two cases: if the end-joining rate constant is much less
than the elongation rate constant, i.e. kj  2k+, N(t) increases slowly as the bulk of the free protein aggregates, increasing
sharply to its long-time value during the late stages of the process (Figure 4 C, r = 0.1). When kj is comparable to or greater
than 2k+, N(t) follows a sigmoidal form similar to M(t) (Figure 4 C, r = 2).
Contrasting behaviour is predicted by the model if the initial seed concentration is sufficiently high. In this case, the model
predicts rapid fibril growth from the start, with no lag phase (figure 4 B, n0 = 1.5). For a small end-joining rate kj  2k+,
M(t) shows a single growth phase, ending in a plateau, while N(t) decays monotonically to its long-time value N∗ (Figures
4 B and C, r = 0.1). Interestingly however, if the end-joining rate constant is significant (kj ' 2k+), the model predicts
two distinct fibril growth phases: the fibril mass concentration M(t) initially grows rapidly, followed by a slower growth
phase, before it eventually reaches a plateau. This behaviour is correlated with the kinetics of the fibril number N(t), which
is non-monotonic: N(t) decreases during the initial growth phase, overshoots its long-time value N∗ and gradually increases
towards N∗ during the second fibril growth phase (Figure 4 C, r = 2).
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Figure 4: Theoretical trajectories of the model described by equations (8)-(9). A) Phase diagram of the system showing four
distinct types of dynamics: [ ] small initial seed population and small end-joining rate (n0 = 0.001, r = 0.1); [·····] small
initial seed population and end-joining rate comparable to elongation (n0 = 0.001, r = 2); [- - - -] high initial seed population
and low end-joining rate (n0 = 1.5, r = 0.1); [ · · ] high end-joining rate and high initial seed population (n0 = 1.5, r = 2).
The dynamics of the normalised fibril mass density m and the normalised fibril number density n for these four cases are
shown in panels (B) and (C), respectively. When the end-joining rate constant is comparable to the elongation rate constant
and the initial seed concentration is also high, fibril growth sites are depleted at early times due to end-joining of fibril ends
before they begin increasing again at later times as a result of fibril breaking; this fluctuation generates a characteristically
delayed equilibration of the fibrillar mass fraction growth curve.
The bi-phasic aggregation kinetics predicted by the model is strikingly similar to our experimental observations for OVA.
Therefore, the model leads us to suggest not only that both fragmentation and end-joining are important for OVA, but also that
in our experiments self-assembly starts with a large number of short but growth-competent species, which due to their small
size may still represent a very small proportion of the total mass fraction. The model also predicts that the absolute number of
fibrils in our experiments (as opposed to the fibril mass) actually decreases in time from its initially high value, before again
increasing.
Thus our theoretical analysis suggests that the kinetics observed in our experiments reflect the interplay between the two
competing processes of fragmentation (which creates new growth-competent ends) and end-joining (which decreases the
number of fibril ends). Initially, growth proceeds rapidly from a seed population that consists of numerous small species.
Later, a relatively high rate of end-joining depletes the number of fibril ends to which free monomers may attach: this process
is manifested by the decrease in the growth rate which is evident in the second observed growth phase. Finally, a small fibril
breakage rate eventually ensures there are enough ends for the remaining free monomers to attach to, bringing the fibril growth
process to completion.
Experimental confirmation of the growth pathway
Fitting our experimental ThT fluorescence curves for ovalbumin (Fig. 3) using our analytical formula (Eq. 16) for the self-
assembly kinetics including end-joining and fragmentation allows us to estimate the relevant kinetic parameters (Fig. 3 C-E).
The initial number density of fibril seeds (i.e. growth-competent species) is indeed estimated to be high (N0/N∗ ≈ 0.5, Fig.
3 E), but these seeds nonetheless represent only a very small proportion of the total amount of protein present (M0  mtot).
Interestingly, the rate constants for elongation and end-joining are of similar magnitudes (Fig. 3 C), suggesting that end-
joining is of comparable importance to the kinetics. As can be seen in Fig. 3 D, the time-scale factor 2k+N∗ increases with
concentration, but the observed dependence is weaker than predicted from the theory (Eq. 7). This, together with the obser-
vation that the ratio N0/N∗ is a constant (Fig. 3 E), implies that N0 is concentration independent and is consistent with our
previous argument that fibril seeds are saturated at surfaces.
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Figure 5: The dynamics for the loop number fraction generated by stochastic simulations for A) heavily seeded growth and B)
for a case exhibiting sigmoidal kinetics. Thin lines represent individual runs, the thick yellow line the ensemble average. We
find that the number of loops is established early in the kinetics for highly seeded growth. This is in contrast to low initial seed
concentrations where the appearance of loops does not happen until further into the growth kinetics and does not reach an
appreciable number until late times. C) Simulated loop perimeter distribution at the mid-point; D) simulated loop perimeter
distribution at the end-point. Both simulated distributions are normalised to the average fibril length at equilibrium.
Having all the relevant parameters in hand, we can perform a simulation of the model using the parameters derived from
fitting of the experimental data, which allow us to monitor evolution of species over time. Due to the high number of fib-
rils forming early during polymerisation, we observe loops forming rapidly during the early stages (Figure 5 A), and then
increasing at a diminishing rate. This gives rise to a loop length distribution that increases fairly sharply at lengths greater
than 2lp and then decays more slowly with increasing loop length (Figure 5 C & D). The length distribution for loops is thus
qualitatively similar with the one observed experimentally, i.e. peaked but with a long tail (Figure 2 E). This loop perimeter
distribution is established early (when less than 50% of the starting material has aggregated) and does not change significantly
over time. Therefore, it may be expected that in systems with flexible fibrils with sufficiently high initial seeding species the
loop population will have formed after the initial growth phase and remain intact until the process is completed. This situation
can be contrasted with the curves displaying sigmoidal kinetics (resulting from small initial seed concentrations) where loops
only appear after some lag-time and only reach an appreciable number when the self-assembly process is almost complete
(Figure 5 B). The model studied in this paper therefore provides a framework for predicting when different fibril morphologies
arise.
It is also worth commenting on the observation that OVA fibrils exhibit branched morphologies (inset to 2 A). We can
show that these branches do not form by fibrils overlapping on the surface of the TEM grid as an artifact of the deposition
process by analysing the angular distribution of the fibril branches (Figure S4). Such branching may occur via two differ-
ent mechanisms: heterogeneous nucleation at a fibril surface or joining of an existing fibril end to the body of another fibril.
Kinetically, these processes are distinct. Heterogeneous nucleation will be a source of new fibril ends, whereas annealing of an
existing fibril end to the body of another fibril will act as a sink by consuming one growth-competent end. Our kinetic analysis
is consistent with a model where fibril ends are depleted rather than created during the aggregation process, suggesting that
the joining of an existing fibril to the body of another occurs during OVA self-assembly under these conditions.
The fact that the rate constants for elongation and end-joining are of similar magnitudes may be due to the flexibility of
the fibrils - for flexible fibrils the correlations between the fibril mass and diffusion of ends dies out relatively quickly; as such,
they may be seen as free-floating particles which react with each other in a manner similar to how they react with monomers.
This may suggest that joining of fibril ends and elongation have similar activation barriers. Such a result is plausible since
both processes involve protein-protein assembly.
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Figure 6: A) Kinetic traces of Th T binding by 6.0 mg/ml OVA at 50 (black circles), 55 (red triangles), 60 (blue diamonds),
65 (green +), 70 (purple squares) and 80◦C (pink *). Symbols represent experimental data; fitted curves are shown as black
solid lines. B) Arrhenius plot for the time scaling factor 2k+N∗ for 6.0 mg/ml OVA. C) Arrhenius plot for the kj/(2k+) ratio
for 6.0 mg/ml OVA. Clearly the latter does not exhibit typical Arrhenius behaviour, indicating that end-joining and elongation
have similar energy barriers.
Analysis of OVA fibril growth kinetics at different temperatures supports this hypothesis (Figure 6 A-C). ThT fluorescence
during the assembly of OVA at a concentration of 6.0 mg/ml was recorded at six different temperatures (50, 55, 60, 65, 70,
and 80◦C). As expected, the fibril formation process is accelerated at higher temperatures. Arrhenius plots show that the ratio
r = kj/(2k+) (see Methods) remains essentially constant with temperature (Figure 6 C), suggesting that end-joining and
elongation have similar activation barriers. This result can easily be understood by first assuming an Arrhenius-like form for
the relevant rate constants, i.e., kj = Ae−(E
†
j /RT ) and likewise for k+. Since our experiments have shown that
d(lnr)
d(1/RT ) ≈ 0,
it follows then that E†j ≈ E†+. Conversely, 2k+N∗ does display Arrhenius behaviour (Figure 6 B). Since, for kf  k+, kj ,
N∗ can be approximated by (mtotkf/kj)1/2, the gradient of the Arrhenius plot
d(ln[2k+N
∗])
d(1/RT ) ≈ −E†+ − 12E†f + 12E†j , where
E† represent activation energies for each process. The energy barrier obtained from Figure 6 B is 97.2 kJ/mol. The similarity
of the energy barriers for end-joining and fibril growth are interesting and may point to these two processes being mechanis-
tically similar, i.e., that a strong parallel may exist between monomer addition at a growth site and the coalescence of two
fibril growth sites. Moreover, as the polymerisation rate changes visibly over the temperature range studied (as evidenced by
Figure 6 A) the energy barrier ought to be comparable to RT at that temperature range (2.7-3.1 kJ/mol), assuming that these
processes are rate-limited. Thus, by far the major contribution to the value obtained from Figure 6 B must originate from the
fragmentation process. These considerations lead to an estimate of 191.2-191.8kJ/mol for E†f which is high compared to RT ,
a result that is entirely consistent with the initial assumption that fragmentation is a slow process. The initial fibrillar mass
fraction does not display any trend as a function of temperature - indeed the fits allow significant variation for this parameter,
given that it is a small number. Notably, temperature does affect the initial seed density with higher temperatures giving rise
to a higher initial seed concentration; thus, whatever the seeding process is, it is temperature-dependent. Nevertheless, even
samples incubated at 50◦C do not display a measurable lag phase, indicating that the initial number of seeds never falls below
the threshold value required for an appreciable lag phase to be observed.
The effect of end-joining on self-assembly dynamics and implications for amyloid-like fibril growth
Our model of ovalbumin self-assembly establishes a link between subtle features of the aggregation kinetics and the molecular
processes underlying self-assembly: in this case the joining between fibril ends. Such processes give rise to the formation of
nano- and micro-scale structures with intriguing morphologies (e.g. loops). Such a model can also be enlisted to interpret a
far wider array of self-assembly phenomena. In the limit of a vanishing end-joining term and a low seed concentration, the
kinetics approach the nucleation, growth and fragmentation model, which begins with a lag phase but is followed by fast
growth, equilibrating rapidly due to its autocatalytic nature (8, 9). Polymerisation with low initial seed concentration and an
end-joining term which effectively cancels out a small fragmentation term qualitatively resembles the classical “nucleation
and growth” case, characterised by a short lag phase followed by a growth phase but with slow equilibration (34). When the
end-joining term is sufficiently high it will effectively inhibit the polymerisation process by removing elongation sites. By
counter-acting the effects of fibril fragmentation, inclusion of end-joining gives rise to kinetic curves that can have either
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abrupt (small end-joining rate constant) or slow (large end-joining rate constant) equilibration following the growth phase.
The fibril length distribution at late times resulting from this case is exponential, a hallmark of polymer fragmentation (35),
but significantly broadened, indicating that end-joining dynamically stabilises large aggregates (see Figure 3 C,E). Thus the
simple inclusion of an end-joining term to the equations describing linear polymerisation and fibril breaking can signifi-
cantly improve the quantitative understanding of protein fibrillisation (and other similar polymerisation reactions) as well as
describing processes, such as those observed for OVA, which cannot be accounted for without it.
The model described by equations (4)-(5) and its solutions (equations (16) as well as (S22) and (S35) can be used to reveal
if end-joining and fragmentation contribute significantly to a fibrillisation process based on the aggregation kinetics. In doing
so, several new questions are opened up. What are the molecular processes that allow end-joining to occur, which may explain
the apparent values of the rate constants? The fact that the systems under question grow linearly into fibrils implies that there
exists a preferred direction for growth (at least once a sufficiently large oligomer has already formed); but can anything be
said about the arrangement of the peptides in the fibril core? In straight amyloid-like fibrils, peptide strands are thought to
exist in a highly ordered, quasi-crystalline state (36, 37). Such an arrangement limits the number of orientations in which
another fibril end may “dock” to an existing end, unless monomers at fibril ends initially have a different configuration before
they adopt that of the fibril interior. Alternatively, the interface between monomers in a fibril may exhibit some structural
heterogeneity, which might, in turn, explain both high end-joining and elongation rates but also the flexibility of the resulting
fibres, observed not only for OVA but for other aggregating proteins (38–40). Thus, end-joining (and possibly elongation)
must either be a multi-stepped processes (“dock and lock”), or a certain degree of structural variability should be expected
along the fibril.
Several proteins form polymorphic fibrils. Some form different fibril morphologies under different environmental con-
ditions (such as in apo-C II (41), a-syn (39, 40), β-2m (12) and OVA (31, 32)). Alternatively some, like Aβ, form flexible,
worm-like fibrils early in the aggregation process before the appearance of rigid fibrils (9). As with OVA, in several other
cases end-joining is implied by the presence of loops (16, 18–23). Notably, aggregation leading to the formation of worm-like
fibrils will often either exhibit a short lag phase, or not exhibit a lag phase at all, indicating that the process giving rise to
the critical concentration of growth-competent species is rapid: is this situation brought about by the inherent stability of the
nucleus for worm-like fibrils or is it a result of worm-like fibrils being able to grow from a heterogeneous mix of monomer
conformations?
Another question, of relevance to the role of amyloid-like fibrils in disease, concerns the toxicity of the fibril population
resulting from this mechanism (which has also been raised by Hatters et al. (16)). In the long-time limit, assuming that the
fibrils do not undergo any further rearrangements, the fibril length distribution will be broad but exponential. For flexible
fibrils, and even with the inclusion of fibril fragmentation, short loops will be present from the initial growth phase onwards
(Figure 5). The consequences of such a fibril length distribution are determined by whether shorter fibrils are cytotoxic. If they
are then it may be expected that the formation of loops will stabilise toxic species, since short loops are indeed very stable
(as they cannot grow any further and their breaking is relatively infrequent due to their small length which limits the number
of possible breakage sites). Intriguingly, closed loops have been shown to form by aggregating α-synuclein (18); furthermore
shorter fibrils formed by fragmentation of larger amyloid fibrils have been found to be more cytotoxic for a number of sys-
tems, including α-synuclein (42). Thus the stabilisation of short species by circularisation could prove detrimental if such
aggregates are cytotoxic. However, if protein oligomers rather than fibrillar aggregates are the toxic species, loop formation
would be desirable as it would lock away the constituent proteins in an inert state for an extended time period; thus, a method
of inducing fibril end-joining would delay the accumulation of toxic species. Thus, relating fibril morphology to the growth
pathway can contribute to rationalising therapeutic strategies for amyloidoses.
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Summary of solutions to fibrillar growth kinetic models involving end-to-end joining
Model Solution Comments
dM/dt = 2k+(mtot −M)N
dN/dt = −kjN2
M(t) = mtot − mtot−M0
(1+kjN0t)
2k+/kj
exact solution for the
fibrillar mass density
M(t)
Eq. (18)
exact implicit
solution N(M),
valid for any
combination of
parameters
dM/dt = 2k+(mtot −M)N
dN/dt = kfM − kjN2
M(t) = mtot − mtot−M0
1− M0
mtot
+
M0
mtot
cosh(2k+N∗t)+
N0
N∗ sinh(2k+N
∗t)
exact solution for
M(t), valid when
kj = 2k+
Eq. (16)
approximate solution
for M(t), valid when
the kinetics are
reminiscent of decay
profiles, lacking a
measurable lag phase
Table 1: M is concentration of monomer incorporated in fibrils (fibril mass density) at any time; N is concentration of fibrils
(number density); M0 is initial fibril mass density; N0 is initial number density of fibrils; mtot is total monomer density;
N∗ ≈√kfmtot/kj is equilibrium number density of fibrils; k+ is linear growth rate constant; kj is end-joining rate constant;
kf is fibril fragmentation rate constant.
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